Key result
Allegra valve-in-valve-in-valve implantation successfully resolves severe aortic stenosis without paravalvular leak.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
This case report demonstrates that early degeneration of a transcatheter valve-in-valve can be successfully treated with a redo transcatheter valve-in-valve-in-valve procedure using the Allegra system and balloon post-dilatation.
An 83-year-old woman presented with dyspnoea NYHA III. Eighteen months ago, she underwent successful transcatheter valve-in-valve implantation (ACURATE Neo ‘S’ in a degenerated 23 mm Perimount valve) (Panel A). Transthoracic echocardiography revealed early degeneration of her transcatheter valve with a peak transaortic jet velocity of 3.7 m/s and a mean transvalvular gradient of 34 mmHg (Panel B). Given her frailty and co-morbidities, the heart team decision was to perform a redo valve-in-valve-in-valve transcatheter procedure. The supra-annular self-expandable transcatheter Allegra heart valve was implanted transfemorally (23 mm NVT Allegra; New Valve Technology, Hechingen, Germany) (valve-in-valve-in-valve, Panel C, Supplementary material online, Video S1). After deployment, a significant transvalvular gradient was present (Panel D) which resolved after post-dilatation using a 20 mm TrueDilatation Balloon (Bard Peripheral Vascular, Tempe, AZ, USA) (Supplementary material online, Video S2) (Panel E). Fluoroscopy showed no paravalvular leak (Panel F, Supplementary material online, Video S3). Our case demonstrates an early degeneration of a transcatheter valve after a valve-in-valve procedure and successful treatment with yet another transcatheter valve. Supplementary material is available at European Heart Journal online. Dr M.M. is a consultant for Japan Lifeline. Dr M.T. is a consultant for Abbott Vascular and 4 Tech. Dr F.N. is a consultant for Edwards Lifescience, Abbott Vascular and Medtronic.
No takes yet. Share an insight, caveat, or question.
Miura et al. (2018) conducted a case report in Early degeneration of a transcatheter valve (ACURATE Neo 'S') following a prior valve-in-valve procedure (n=1). Transfemoral valve-in-valve-in-valve implantation with a 23 mm NVT Allegra transcatheter heart valve and 20 mm balloon post-dilatation was evaluated on Resolution of transvalvular gradient and absence of paravalvular leak. Transfemoral 23 mm Allegra valve-in-valve-in-valve implantation with 20 mm balloon post-dilatation resolved a 34 mmHg transvalvular gradient without paravalvular leak in an 83-year-old woman.
Synapse has enriched 10 related papers. Consider them for comparative context: